TWINE Effect receives official injectable recognition in the UK
TWINE Medical is pleased to announce that TWINE Effect, its advanced deoxycholic acid-based lipolytic solution, has been officially approved as an injectable treatment in the United Kingdom under an accredited Product Training program.
This certification is accredited and recognized by the CPD Group, a leading UK accreditation body and INSYNC Insurance, ensuring compliance and safety for practitioners offering lipotherapy, intralipotherapy and fat-dissolving treatments using deoxycholic acid.
Accredited Training and Insurance Recognition
The approval of TWINE Effect under this training program provides medical and aesthetic practitioners with:
- Certified Training: practitioners can now receive official instruction in TWINE Effect lipotherapy and intralipotherapy techniques.
- CPD Accreditation: the program meets the Continuing Professional Development (CPD) Group’s standards, ensuring professional excellence.
- INSYNC Insurance Recognition: coverage is available for practitioners performing fat-dissolving procedures with TWINE Effect.
This recognition further establishes TWINE Effect as a trusted and high-quality solution for non-surgical fat reduction, ensuring that treatments are conducted under accredited and insured conditions in the UK.
For more details on the accreditation and training program, visit the official CPD Register page: CPD Register – Intralipotherapy Fat-Dissolving Training.
For further inquiries about training and certification, please contact us here.